BiOptix Unveils a New Brand Identity reflecting an expansion into the Surface Plasmon Resonance (SPR) Marketplace with a novel and patented technology Introducing ESPR—Enhanced Surface Plasmon Resonance from BiOptix. Scientific instrumentation designed to deliver Kinetics with Confidence.
BOULDER, Colo., April 26, 2012 /PRNewswire/ -- BiOptix today formally unveiled a new corporate brand identity and tag line: "Kinetics with Confidence," which is designed to promote the company's mission to transform how scientists perform label free kinetic analysis on proteins, nucleic acids and small molecules.
"BiOptix is rapidly expanding, and we needed a brand and corporate identity that reflects the aspirations of the company as well as communicates our value proposition to our core customer base," noted Ken Wilczek, Vice President of Sales and Marketing. Mr. Wilczek added that the company will be participating in more than 15 customer-facing events within the next several weeks, with more to follow in the second half of 2012. "This is an exciting time at BiOptix. In addition to the launch of our new brand identity, we are beginning a vigorous event schedule which will allow us to visit with thousands of life-science researchers and discuss the BiOptix 104sa, the 404pi as well as our proprietary Enhanced SPR technology."
Surface Plasmon Resonance is an advanced and highly sensitive optical technology that can measure refractive index changes on a sensor chip's gold surface due to a change in mass that occurs during a binding event. This change can be used to monitor biological interactions such as the concentration of target molecules, kinetic rates and affinity constants. BiOptix has developed and patented a novel ultra-sensitive detection platform known as Enhanced Surface Plasmon resonance, or ESPR. Unlike traditional SPR, ESPR instrumentation from BiOptix enables the high sensitivity of SPR with the high stability and lower noise of common path interferometry.
BiOptix Diagnostics Corporation, a privately held firm based in Boulder, Colorado has developed a new class of analytical biosensor instrumentation utilizing a patented high-throughput label-free technology known as ESPR – Enhanced Surface Plasmon Resonance. BiOptix instrumentation allows researchers to study label-free protein-protein and protein-small molecule interaction—with high sensitivity and high throughput. Applications include: Protein-small molecule interactions, protein-protein kinetics, antibody affinities and epitope mapping, oligosaccharide characterization, nucleic acid (DNA-DNA or DNA-RNA) hybridization and biomolecule concentration measurements. Additional information about BiOptix and our products can be found at: www.bioptix.com
SOURCE BiOptix Diagnostics Corporation